Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Schmidt

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
BMC Medical Education|July 15, 2020
The impact of an audience response system on a summative assessment, a controlled field studyThorsten Schmidt, Anastasia Gazou, Angelika Rieß, et al.
Cellular and Molecular Life Sciences : CMLS|July 6, 2022
KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPPMahkameh Abeditashi, Jonasz Jeremiasz Weber, Priscila Pereira Sena, et al.
BMC Genomics|December 26, 2008
An evolutionary and structural characterization of mammalian protein complex organizationPhilip Wong, Sonja Althammer, Andrea Hildebrand, et al.
Frontiers in Molecular Neuroscience|June 5, 2023
Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph diseasePriscila Pereira Sena, Jonasz Jeremiasz Weber, Sercan Bayezit, et al.
Brain : a Journal of Neurology|June 10, 2011
N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocationJeannette Hübener, Franz Vauti, Claudia Funke, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2007
Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidenceUlrike Bichelmeier, Thorsten Schmidt, Jeannette Hübener, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug DiscoveryWerngard Czechtizky, Jüergen Dedio, Bimbisar Desai, et al.
Scientific Reports|November 8, 2019
Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight lossPernille Barkholt, Kristoffer T G Rigbolt, Mechthilde Falkenhahn, et al.
Molecular Neurobiology|October 30, 2021
A Novel SCA3 Knock-in Mouse Model Mimics the Human SCA3 Disease Phenotype Including Neuropathological, Behavioral, and Transcriptional Abnormalities Especially in OligodendrocytesEva Haas, Rana D Incebacak, Thomas Hentrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2021
Pathophysiological interplay between <i>O</i>-GlcNAc transferase and the Machado-Joseph disease protein ataxin-3Priscila Pereira Sena, Jonasz J Weber, Maxinne Watchon, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
BMC Medical Education|July 15, 2020
The impact of an audience response system on a summative assessment, a controlled field studyThorsten Schmidt, Anastasia Gazou, Angelika Rieß, et al.
Cellular and Molecular Life Sciences : CMLS|July 6, 2022
KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPPMahkameh Abeditashi, Jonasz Jeremiasz Weber, Priscila Pereira Sena, et al.
BMC Genomics|December 26, 2008
An evolutionary and structural characterization of mammalian protein complex organizationPhilip Wong, Sonja Althammer, Andrea Hildebrand, et al.
Frontiers in Molecular Neuroscience|June 5, 2023
Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph diseasePriscila Pereira Sena, Jonasz Jeremiasz Weber, Sercan Bayezit, et al.
Brain : a Journal of Neurology|June 10, 2011
N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocationJeannette Hübener, Franz Vauti, Claudia Funke, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 13, 2007
Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidenceUlrike Bichelmeier, Thorsten Schmidt, Jeannette Hübener, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug DiscoveryWerngard Czechtizky, Jüergen Dedio, Bimbisar Desai, et al.
Scientific Reports|November 8, 2019
Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight lossPernille Barkholt, Kristoffer T G Rigbolt, Mechthilde Falkenhahn, et al.
Molecular Neurobiology|October 30, 2021
A Novel SCA3 Knock-in Mouse Model Mimics the Human SCA3 Disease Phenotype Including Neuropathological, Behavioral, and Transcriptional Abnormalities Especially in OligodendrocytesEva Haas, Rana D Incebacak, Thomas Hentrich, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2021
Pathophysiological interplay between <i>O</i>-GlcNAc transferase and the Machado-Joseph disease protein ataxin-3Priscila Pereira Sena, Jonasz J Weber, Maxinne Watchon, et al.
Pageof 12